Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
about
BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteinsThe p65 subunit is responsible for the strong transcription activating potential of NF-kappa BA novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B siteRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsCleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosinToxin-based therapeutic approachesIn silico prediction of mutant HIV-1 proteases cleaving a target sequenceHIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentationHuman immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cellsInducible processing of interferon regulatory factor-2Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminusRequirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance.Proteasome-independent activation of nuclear factor kappaB in cytoplasmic extracts from human endothelial cells by Rickettsia rickettsiiA cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method.A nuclear matrix-specific factor that binds a specific segment of the negative regulatory element (NRE) of HIV-1 LTR and inhibits NF-kappa(B) activityHuman immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activationThe C terminus of the NF-kappa B p50 precursor and an I kappa B isoform contain transcription activation domains.Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activationMoloney murine leukemia virus activates NF-kappa BChronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradationMultiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cellsNF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection.A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunitThe bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa BChronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activationExtracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cellsHerpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kappa B enhancer and leader sequencep105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex.Bioinformatic approaches for modeling the substrate specificity of HIV-1 protease: an overview.NF-kappa B-dependent induction of the NF-kappa B p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells.Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2The nfkb1 promoter is controlled by proteins of the Ets family.
P2860
Q24315909-48F14058-0335-4566-8669-5E4811C20FAEQ24564667-A82CDA70-32E9-4F18-9800-CAC89B3E21DAQ24630534-AB66D909-4312-47FF-B990-78BFA3A2F0F0Q24651506-57B9485E-D4D9-403B-9A76-46C9091D0956Q24676673-FE0F9149-C571-4E98-A116-02D61260E785Q27013664-F70CA5DE-86C2-4B9B-A5DE-4CB1C40A8AA6Q27335448-A32AA705-7DD8-4DC7-9C53-C04228CCC68CQ28211642-1CFC2107-9E8F-4C72-9229-6F89B45717BBQ28318483-CD5F159F-0118-4DAB-AA2A-CF43B4367A12Q28610440-6D8ECCF2-6897-4956-AE88-2A4D159F422BQ28614547-D94A513D-B2A9-4CEA-9220-E0ABF68DCF4AQ30452154-ED757507-668D-4B72-87F3-06612E4E6320Q30452167-5E5CFE6F-C282-4222-9A10-EAD7131282A5Q33592125-72A7CE91-4C88-4120-A951-24A31B61211CQ33753131-D4702F40-CC73-41E8-ACF4-5E9E8F4EC37CQ34059393-030E92C5-9F09-4F6D-AD02-D174F76CA8DCQ34379398-E1271603-C399-4ECA-94E1-95D3C8400B16Q34597244-6DDAF4D8-BD04-433D-B0F5-5781D3DEB7CEQ34664366-2AED0880-7985-4A66-A9D8-05264FE383C2Q34756370-C85E1C21-E1A8-45EC-A731-CDD0FDAEA17CQ35069893-10A21830-BCA0-4081-AA2B-46723903BA7BQ35551066-B0656ADD-8F74-46B9-82E1-B29A0597560CQ35862437-A61E4A79-506E-47C4-9B50-5401E8CF0090Q35865967-85CBCE29-3976-4C50-85C2-D8768B3714F5Q36090467-85FA1152-FE4B-420D-AE13-BC554B633231Q36231067-77BF8736-CFFB-4F47-8D55-06724E386C76Q36478121-6F4FE03B-EC44-484E-A5B8-4209B34BAEDDQ36559257-E9F2552E-586F-488F-B5F7-F48105835635Q36648227-DD27526D-C8E6-4626-8CB6-21693844F1D8Q36651776-4488A231-F70A-4291-A810-254E4B67A75FQ36655517-862E6F75-AECE-422F-A3FD-9C1653DD0BFAQ36666995-D43A3CE6-939F-4EAF-BE46-570FBDD079E1Q36691239-A477D448-B0A7-4236-9FE8-274F3232A2CAQ36698102-8711C711-FD6C-445E-A5A1-D637D2DD008EQ36698264-561DE214-384C-4666-95C3-6A8BD016FAD7Q36817938-BCE1BB50-F222-40EF-93D8-474EF214231BQ36874356-0E5598B9-2064-43C7-8127-E124B0EA7793Q37166030-79BCA3A0-43E6-445D-A5FB-384DA49AAEB8Q37356313-5B6E3738-3BCA-4313-89D5-1E2ED5CFC546Q37384802-E0EA9893-EDD5-4510-A462-2616C64DC0F4
P2860
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
@en
type
label
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
@en
prefLabel
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
@en
P2093
P356
P1433
P1476
Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.
@en
P2093
P2888
P304
P356
10.1038/350625A0
P407
P577
1991-04-01T00:00:00Z
P6179
1018538362